Ranibizumab (Lucentis®, Novartis Europharm Limited, Dublin, Ireland) and aflibercept (Eylea®, Bayer AG, Leverkusen, Germany) are licensed intravitreal anti-VEGF drugs (antiangiogenic agents) indicated for adults for the treatment of nAMD as well as for visual impairment due to other retinal co...
my question was and is still related to your reply found above "...the ones that get pushed out are the ones the full scan just put in there...". let me try to refine. i know that the fts places its blocks at the cold end of the lru list per definition. but how can it ...